GALLIPOLIS, Ohio — The use of GLP-1 medications such as Ozempic, Wegovy, Mounjaro and Zepbound continues to grow across Southeast Ohio and Southern West Virginia as more patients seek treatment for Type 2 diabetes and obesity, two chronic health conditions…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.